Reassessing the Incidence and Risk Factors of Radiation Pneumonitis in Treatment-Naive EGFR-Mutant NSCLC With Concurrent Third-Generation EGFR-TKI and Thoracic Radiotherapy.

Tagrisso (osimertinib) - AstraZeneca

Ameile (aumolertinib) - Jiangsu Hansoh Pharma

Ivesa (firmonertinib) - Allist, ArriVent

http://www.ncbi.nlm.nih.gov/pubmed/42363769

Feihu Chen; Hui Zhu; Jinming Yu; Li Li; Shuyue Zheng; Wenxiao Jia; Xuquan Jing; Yaru Tian; Zhijun Guo

Jun 28, 2026